Average Co-Inventor Count = 1.94
ph-index = 11
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Amgen Inc. (9 from 1,970 patents)
2. Other (6 from 832,680 patents)
3. Advenchen Pharmaceuticals, LLC (5 from 6 patents)
4. Advenchen Laboratories, LLC (2 from 2 patents)
5. Advenchen Pharmaceuticals, Nanjing Ltd. (0 patent)
6. Chen, Guoqing Paul (0 patent)
22 patents:
1. 10544125 - Process for preparing an anti-cancer agent, 1-((4-(4-fluoro-2-methyl-1H-indol-5-yloxy)-6-methoxyquinolin-7-yloxy)methyl)cyclopropanamine, its crystalline form and its salts
2. 10112945 - Fused quinoline compunds as PI3K, mTOR inhibitors
3. 10100034 - Process for preparing an anti-cancer agent, 1-((4-(4-fluoro-2-methyl-1H-indol-5-yloxy)-6-methoxyquinolin-7-yloxy)methyl)cyclopropanamine, its crystalline form and its salts
4. 9783498 - Process for preparing the anti-tumor agent 6-(7-((1-aminocyclopropyl)methoxy)-6-methoxyquinolin-4-yloxy)-N-methyl-1-naphthamide and its crystalline
5. 9751859 - Process for preparing an anti-cancer agent, 1-((4-(4-fluoro-2-methyl-1H-indol-5-yloxy)-6-methoxyquinolin-7-yloxy)methyl)cyclopropanamine, its crystalline form and its salts
6. 8664244 - Compounds as c-Met kinase inhibitors
7. 8642624 - Substituted alkylamine derivatives and methods of use
8. 8513283 - Spiro substituted compounds as angiogenesis inhibitors
9. 8211911 - Compounds as kinase inhibitors
10. 8163923 - Spiro substituted compounds as angiogenesis inhibitors
11. 8148532 - Spiro substituted compounds as angiogenesis inhibitors
12. 7977346 - Spiro compounds and methods of use
13. 7514564 - Substituted amine derivatives and methods of use
14. 7307088 - Substituted anthranilic amide derivatives and methods of use
15. 7232825 - Phenylaminopyrimidine derivatives and methods of use